These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 26502195)

  • 1. Cross-disease comparison of amyotrophic lateral sclerosis and spinal muscular atrophy reveals conservation of selective vulnerability but differential neuromuscular junction pathology.
    Comley LH; Nijssen J; Frost-Nylen J; Hedlund E
    J Comp Neurol; 2016 May; 524(7):1424-42. PubMed ID: 26502195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant superoxide dismutase 1 (SOD1), a cause of amyotrophic lateral sclerosis, disrupts the recruitment of SMN, the spinal muscular atrophy protein to nuclear Cajal bodies.
    Kariya S; Re DB; Jacquier A; Nelson K; Przedborski S; Monani UR
    Hum Mol Genet; 2012 Aug; 21(15):3421-34. PubMed ID: 22581780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Nagahara Y; Shimazawa M; Tanaka H; Ono Y; Noda Y; Ohuchi K; Tsuruma K; Katsuno M; Sobue G; Hara H
    J Neurosci Res; 2015 Oct; 93(10):1552-66. PubMed ID: 26140698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy.
    Murray LM; Comley LH; Thomson D; Parkinson N; Talbot K; Gillingwater TH
    Hum Mol Genet; 2008 Apr; 17(7):949-62. PubMed ID: 18065780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.
    Turner BJ; Bäumer D; Parkinson NJ; Scaber J; Ansorge O; Talbot K
    BMC Neurosci; 2008 Oct; 9():104. PubMed ID: 18957104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional profiling of differentially vulnerable motor neurons at pre-symptomatic stage in the Smn (2b/-) mouse model of spinal muscular atrophy.
    Murray LM; Beauvais A; Gibeault S; Courtney NL; Kothary R
    Acta Neuropathol Commun; 2015 Sep; 3():55. PubMed ID: 26374403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective neuromuscular junction organization and postnatal myogenesis in mice with severe spinal muscular atrophy.
    Dachs E; Hereu M; Piedrafita L; Casanovas A; Calderó J; Esquerda JE
    J Neuropathol Exp Neurol; 2011 Jun; 70(6):444-61. PubMed ID: 21572339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene.
    Park GH; Maeno-Hikichi Y; Awano T; Landmesser LT; Monani UR
    J Neurosci; 2010 Sep; 30(36):12005-19. PubMed ID: 20826664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice.
    Turner BJ; Alfazema N; Sheean RK; Sleigh JN; Davies KE; Horne MK; Talbot K
    Neurobiol Aging; 2014 Apr; 35(4):906-15. PubMed ID: 24210254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptotagmin-2, and -1, linked to neurotransmission impairment and vulnerability in Spinal Muscular Atrophy.
    Tejero R; Lopez-Manzaneda M; Arumugam S; Tabares L
    Hum Mol Genet; 2016 Nov; 25(21):4703-4716. PubMed ID: 28173138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptic withdrawal following nerve injury is influenced by postnatal maturity, muscle-specific properties, and the presence of underlying pathology in mice.
    Mole AJ; Bell S; Thomson AK; Dissanayake KN; Ribchester RR; Murray LM
    J Anat; 2020 Aug; 237(2):263-274. PubMed ID: 32311115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Neuromuscular Denervation in Taiwanese Severe SMA Mouse Can Be Reversed by Morpholino Antisense Oligonucleotides.
    Lin TL; Chen TH; Hsu YY; Cheng YH; Juang BT; Jong YJ
    PLoS One; 2016; 11(4):e0154723. PubMed ID: 27124114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology.
    Bowerman M; Murray LM; Beauvais A; Pinheiro B; Kothary R
    Neuromuscul Disord; 2012 Mar; 22(3):263-76. PubMed ID: 22071333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Muscle-Specific Kinase (MuSK) Reduces Neuromuscular Defects in the Delta7 Mouse Model of Spinal Muscular Atrophy (SMA).
    Feng Z; Lam S; Tenn ES; Ghosh AS; Cantor S; Zhang W; Yen PF; Chen KS; Burden S; Paushkin S; Ayalon G; Ko CP
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
    J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model.
    Turner BJ; Parkinson NJ; Davies KE; Talbot K
    Neurobiol Dis; 2009 Jun; 34(3):511-7. PubMed ID: 19332122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic commonalities between spinal muscular atrophy and amyotrophic lateral sclerosis: Converging roads to therapeutic development.
    Bowerman M; Murray LM; Scamps F; Schneider BL; Kothary R; Raoul C
    Eur J Med Genet; 2018 Nov; 61(11):685-698. PubMed ID: 29313812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy.
    Dachs E; Piedrafita L; Hereu M; Esquerda JE; Calderó J
    Neuroscience; 2013 Oct; 250():417-33. PubMed ID: 23876328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy.
    Riessland M; Ackermann B; Förster A; Jakubik M; Hauke J; Garbes L; Fritzsche I; Mende Y; Blumcke I; Hahnen E; Wirth B
    Hum Mol Genet; 2010 Apr; 19(8):1492-506. PubMed ID: 20097677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.